147-94-4 , Arabinocytidine,
CAS: 147-94-4
C9H13N3O5 / 243.22
MFCD00066487
1-(b-D-Arabinofuranosyl)cytosine
Cytarabine is also know as cytosine arabinoside (ara-C) and is a chemotherapy drug that works by inhibiting DNA synthesis. It acts as a nucleoside analogue, which is incorporated into the growing DNA chain during replication. Cytarabine combines a cytosine base with an arabinose sugar (1β-arabinofuranosylcytosine) and is an analog for human deoxycytosine. Cytarabine interferes with DNA synthesis as it is rapidly converted to cytosine arabinoside triphosphate, damaging DNA when cells are in the syntheis phase (S phase). Tumor cells which are highly mitotic and growing rapidly are therefore prefertially targeted. Cytarabine also inhibits nucleotide reductase enzymes as well as nuclear polymerases, leading to interruption and inhibition of synthesis, strand breaks and cell death.
Title: Cytarabine
CAS Registry Number: 147-94-4
CAS Name: 4-Amino-1-b-D-arabinofuranosyl-2(1H)-pyrimidinone
Additional Names: 1-b-D-arabinofuranosylcytosine; Ara-C; b-cytosine arabinoside; aracytidine
Manufacturers' Codes: CHX-3311; U-19920
Trademarks: Alexan (Ebewe); Aracytine (Pfizer); Cytosar (Pharmacia & Upjohn); Depocyte (Pharmacia); Udicil (Pharmacia & Upjohn)
Molecular Formula: C9H13N3O5
Molecular Weight: 243.22
Percent Composition: C 44.44%, H 5.39%, N 17.28%, O 32.89%
Literature References: Nucleoside analog; converted by cellular kinases into the active metabolite, AraCTP. Prepn: J. H. Hunter, US 3116282 (1963 to Upjohn); T. Y. Shen et al., J. Org. Chem. 30, 835 (1965). NMR soln structure of Ara-C within a DNA dodecamer: B. I. Schweitzer et al., Biochemistry 33, 11460 (1994). Crystal structure of complex with human topoisomerase I: J. E. Chrencik et al., J. Biol. Chem. 278, 12461 (2003). Clinical pharmacology and toxicology: R. C. Donehower et al., Cancer Treat. Rep. 70, 1059 (1986). Symposium on clinical pharmacology, pharmacokinetics and efficacy in leukemia: Scand. J. Haematol. 36, Suppl. 44, 1-74 (1986). Review of development of a high dose treatment for acute myeloid leukemia: R. L. Capizzi, Invest. New Drugs 14, 249-256 (1996); of cellular metabolism and mechanism of action: S. Grant, Adv. Cancer Res. 72, 197-233 (1998).
Properties: Crystals from ethanol, mp 212-213°. [a]D24 +153° (c = 0.5 in water). uv max at pH 2: 281.0, 212.5 nm (e 13171, 10230); at pH 12: 272.5 nm (e 9259).
Melting point: mp 212-213°
Optical Rotation: [a]D24 +153° (c = 0.5 in water)
Absorption maximum: uv max at pH 2: 281.0, 212.5 nm (e 13171, 10230); at pH 12: 272.5 nm (e 9259)
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic; Antimetabolites; Pyrimidine Analogs.
CAS Number | 147-94-4 |
Product Name | Cytarabine |
IUPAC Name | 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
Molecular Formula | C9H13N3O5 |
Molecular Weight | 243.22 g/mol |
InChI | InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1 |
InChI Key | UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
SMILES | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O |
Solubility | Freely soluble |
Synonyms | Ara C, Ara-C, Arabinofuranosylcytosine, Arabinoside, Cytosine, Arabinosylcytosine, Aracytidine, Aracytine, beta Ara C, beta-Ara C, Cytarabine, Cytarabine Hydrochloride, Cytonal, Cytosar, Cytosar U, Cytosar-U, Cytosine Arabinoside |
Canonical SMILES | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O |
Isomeric SMILES | C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O |
CAS No: 147-94-4 Synonyms: Cytosine-b-D-arabinofuranosideCytarabine4-Amino-1-(b-D-Arabinofuranosyl)-2(1H)pyrimidinone MDL No: MFCD00066487 Chemical Formula: C9H13N3O5 Molecular Weight: 243.22 |
COA:
Name: Cytosine β-D-Arabinofuranoside;Arabinocytidine
CAS: 147-94-4 M.F.: C9H13N3O5 M.W.: 243.22
Items | Standards | Results |
Appearance | White powder | Positive |
Solubility | Soluble in water and almost insoluble in ether | Complies |
Appearance of solution | Dissolve1gin 100mL of water, and the solution should be clear and colorless | Complies |
Identification | IR and HPLC | Comply |
NMR and MS | Should comply | Positive |
Residue on ignition | Max. 0.5% | 0.02% |
Specific rotation | +154°~ +160° | +156° |
Heavy metals | Max. 20ppm | Complies |
Loss Weight On Dryness | Max. 1% | 0.24% |
Assay | Min. 99% | 99.6% |
References:
1. Donehower RC, et al., Cancer Treat. Rep. 1986, 70, p1059
Contact: Miss.Xing
Phone: 18310328607 , 13621067991,13552979007
Tel: 86+10-61274189
Email: chemsynlab@163.com, zhangchao@chemsynlab.com
Add: A411 Room,No.26,Jinyuan Road,Daxing Industrial Developing District,Beijing,China post code:102628